Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cempra Pharma Completes Phase 1 Studies For CEM-101
According to Cempra Pharma, CEM-101 is expected to be the first macrolide to have an intravenous formulation available in the US since intravenous azithromycin was approved in 1997,
According to Cempra Pharma, CEM-101 is expected to be the first macrolide to have an intravenous formulation available in the US since intravenous azithromycin was approved in 1997,
Orphan-drug designation will be granted by the FDA Office of Orphan Drug Products Development to novel drugs or biologics that may treat a condition affecting less than 200,000
Limerick BioPharma said that LIM-0705 is a small-molecule compound being developed to administer alongside tacrolimus, a calcineurin inhibitor widely used to block the body from rejecting transplanted organs.
Ipsen, a global biotechnology specialty care group and the TMX-67 licensee in Europe, and its sublicensee the Menarini Group, have began marketing the product in Europe under the
Reportedly, the British-Swedish pharma major had filed two lawsuits against Sun Pharma and its US subsidiary on February 26 in a federal court in Trenton, New Jersey, and
Stefan Oschmann, president of emerging markets at Merck, said that the company’s endeavors of this proposed expansion will lead to increase in sales in the region by 30%,
Takeda Pharma North America will start marketing the drug under the new name in late April 2010. After Kapidex was approved in January 2009, there have been reports
The company said that in Stage B of the study of H1N1 influenza vaccine candidate, a group of 3,500 healthy volunteers aged 18 to 64 years old were
The three new products add to the company’s line of açai superfruit offerings including AçaiBerry 1,000mg, AçaíBerry Diet and AçaíBerry Weekend Cleanse. MaquiBerry are deep colored berries that
Wacker Chemie said that the expansion will enable it to accommodate its customers’ growing demand for biotechnologically manufactured pharmaceuticals. Biologics are used to treat, among other things, cancer,